Cashu
United Therapeutics Set for Key Earnings Report Amid Biotech Innovations and Market Optimism
about 8 hours ago
Stocks
Health Care
uthr
United Therapeutics
NASDAQ: UTHR
-1.71 (-0.38%)
453.61
USD
At close at Oct 30, 20:38 UTC
Overview
Loading chart...
Key Stats
Market Cap
20.54B
Dividend Yield
0.00%
P/E Ratio
16.53
EPS
26.42
Revenue
2.88B
Avg. Volume
793.58K
About
What does UTHR do?
United Therapeutics, based in Silver Spring, Maryland, develops therapies for chronic conditions, primarily focusing on pulmonary arterial hypertension with products like Tyvaso and Remodulin. The company also offers Unituxin for high-risk neuroblastoma and employs 1,168 people.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.